BTC Health Limited (BTC.AX)
AUD 0.06
(0.0%)
AUD 0.06
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 1.05 Million AUD | 110.38% |
| 2023 | -10.16 Million AUD | -1665.02% |
| 2022 | -576.07 Thousand AUD | -47.08% |
| 2021 | -391.68 Thousand AUD | -38.39% |
| 2020 | -283.03 Thousand AUD | 59.14% |
| 2019 | -692.74 Thousand AUD | 52.81% |
| 2018 | -1.46 Million AUD | -184.17% |
| 2017 | -516.52 Thousand AUD | -202.45% |
| 2016 | -870.78 Thousand AUD | 66.32% |
| 2015 | -507.01 Thousand AUD | 73.16% |
| 2014 | -1.88 Million AUD | -276.48% |
| 2013 | -501.74 Thousand AUD | 73.03% |
| 2012 | -1.86 Million AUD | 46.78% |
| 2011 | -3.49 Million AUD | 38.76% |
| 2010 | -5.7 Million AUD | -31.71% |
| 2009 | -4.33 Million AUD | 41.33% |
| 2008 | -7.38 Million AUD | -873.12% |
| 2007 | -759 Thousand AUD | -106.81% |
| 2006 | -367 Thousand AUD | 68.39% |
| 2005 | -1.57 Million AUD | 0.0% |
| 2004 | -4.65 Million AUD | 100.0% |
| 2003 | -3000.00 AUD | -103.49% |
| 2002 | 86 Thousand AUD | -86.67% |
| 2001 | 645 Thousand AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q4 | 324.12 Million AUD | 0.0% |
| 2024 Q2 | 311.48 Million AUD | 0.0% |
| 2024 FY | 1.05 Million AUD | 110.38% |
| 2023 FY | -10.16 Million AUD | -1665.02% |
| 2023 Q4 | 281.84 Million AUD | 0.0% |
| 2023 Q2 | 281.84 Million AUD | 0.0% |
| 2022 FY | -576.07 Thousand AUD | -47.08% |
| 2022 Q4 | -219.22 Thousand AUD | 0.0% |
| 2022 Q2 | -356.85 Thousand AUD | 0.0% |
| 2021 FY | -391.68 Thousand AUD | -38.39% |
| 2021 Q4 | -212.74 Thousand AUD | 0.0% |
| 2021 Q2 | -178.94 Thousand AUD | 0.0% |
| 2020 Q4 | -61.74 Thousand AUD | 0.0% |
| 2020 FY | -283.03 Thousand AUD | 59.14% |
| 2020 Q2 | -221.28 Thousand AUD | 0.0% |
| 2019 Q4 | -447.15 Thousand AUD | 0.0% |
| 2019 FY | -692.74 Thousand AUD | 52.81% |
| 2019 Q2 | -245.58 Thousand AUD | 0.0% |
| 2018 FY | -1.46 Million AUD | -184.17% |
| 2018 Q2 | -1.38 Million AUD | 0.0% |
| 2018 Q4 | -78.71 Thousand AUD | 0.0% |
| 2017 Q2 | -201.22 Thousand AUD | 0.0% |
| 2017 FY | -516.53 Thousand AUD | -202.45% |
| 2017 Q4 | -315.3 Thousand AUD | 0.0% |
| 2016 Q4 | -791.17 Thousand AUD | 0.0% |
| 2016 Q2 | -79.6 Thousand AUD | 0.0% |
| 2016 FY | -170.78 Thousand AUD | 66.32% |
| 2015 FY | -507.01 Thousand AUD | 73.16% |
| 2015 Q4 | -387.66 Thousand AUD | 0.0% |
| 2015 Q2 | -119.35 Thousand AUD | 0.0% |
| 2014 Q4 | -68.03 Thousand AUD | 0.0% |
| 2014 FY | -1.88 Million AUD | -276.48% |
| 2014 Q2 | -1.82 Million AUD | 0.0% |
| 2013 Q4 | -64.61 Thousand AUD | 48.49% |
| 2013 Q2 | -437.13 Thousand AUD | 6.0% |
| 2013 Q3 | -125.43 Thousand AUD | 71.3% |
| 2013 Q1 | -465.04 Thousand AUD | 0.0% |
| 2013 FY | -501.74 Thousand AUD | 73.03% |
| 2012 Q4 | -465.04 Thousand AUD | 0.0% |
| 2012 Q2 | -465.04 Thousand AUD | 46.78% |
| 2012 Q1 | -873.75 Thousand AUD | 0.0% |
| 2012 FY | -1.86 Million AUD | 46.78% |
| 2012 Q3 | -465.04 Thousand AUD | 0.0% |
| 2011 Q3 | -873.75 Thousand AUD | 0.0% |
| 2011 FY | -3.49 Million AUD | 38.76% |
| 2011 Q4 | -873.75 Thousand AUD | 0.0% |
| 2011 Q2 | -873.75 Thousand AUD | 38.76% |
| 2011 Q1 | -1.42 Million AUD | 0.0% |
| 2010 Q2 | -1.42 Million AUD | -31.71% |
| 2010 Q3 | -1.42 Million AUD | 0.0% |
| 2010 Q4 | -1.42 Million AUD | 0.0% |
| 2010 FY | -5.7 Million AUD | -31.71% |
| 2010 Q1 | -1.08 Million AUD | 0.0% |
| 2009 Q4 | -1.08 Million AUD | 0.0% |
| 2009 Q1 | -1.84 Million AUD | 0.0% |
| 2009 Q2 | -1.08 Million AUD | 41.33% |
| 2009 Q3 | -1.08 Million AUD | 0.0% |
| 2009 FY | -4.33 Million AUD | 41.33% |
| 2008 Q1 | -189.75 Thousand AUD | 0.0% |
| 2008 Q4 | -1.84 Million AUD | 0.0% |
| 2008 Q3 | -1.84 Million AUD | 0.0% |
| 2008 FY | -7.38 Million AUD | -873.12% |
| 2008 Q2 | -1.84 Million AUD | -873.12% |
| 2007 Q4 | -189.75 Thousand AUD | 0.0% |
| 2007 Q3 | -189.75 Thousand AUD | 0.0% |
| 2007 Q2 | -189.75 Thousand AUD | -106.81% |
| 2007 Q1 | -91.75 Thousand AUD | 0.0% |
| 2007 FY | -759 Thousand AUD | -106.81% |
| 2006 Q2 | -91.75 Thousand AUD | 68.39% |
| 2006 Q3 | -91.75 Thousand AUD | 0.0% |
| 2006 FY | -367 Thousand AUD | 68.39% |
| 2006 Q4 | -91.75 Thousand AUD | 0.0% |
| 2006 Q1 | -290.25 Thousand AUD | 0.0% |
| 2005 Q1 | - AUD | 0.0% |
| 2005 Q4 | -290.25 Thousand AUD | 0.0% |
| 2005 FY | -1.16 Million AUD | 0.0% |
| 2005 Q3 | -290.25 Thousand AUD | 0.0% |
| 2005 Q2 | -290.25 Thousand AUD | 0.0% |
| 2004 Q1 | -750.00 AUD | 0.0% |
| 2004 Q2 | - AUD | 100.0% |
| 2004 FY | - AUD | 100.0% |
| 2004 Q4 | - AUD | 0.0% |
| 2004 Q3 | - AUD | 0.0% |
| 2003 Q3 | -750.00 AUD | 0.0% |
| 2003 FY | -3000.00 AUD | -103.49% |
| 2003 Q1 | 21.5 Thousand AUD | 0.0% |
| 2003 Q2 | -750.00 AUD | -103.49% |
| 2003 Q4 | -750.00 AUD | 0.0% |
| 2002 Q1 | 161.25 Thousand AUD | 0.0% |
| 2002 Q4 | 21.5 Thousand AUD | 0.0% |
| 2002 FY | 86 Thousand AUD | -86.67% |
| 2002 Q2 | 21.5 Thousand AUD | -86.67% |
| 2002 Q3 | 21.5 Thousand AUD | 0.0% |
| 2001 Q4 | 161.25 Thousand AUD | 0.0% |
| 2001 Q2 | 161.25 Thousand AUD | 0.0% |
| 2001 Q1 | - AUD | 0.0% |
| 2001 FY | 645 Thousand AUD | 0.0% |
| 2001 Q3 | 161.25 Thousand AUD | 0.0% |
| 2000 Q2 | - AUD | 0.0% |
| 2000 Q4 | - AUD | 0.0% |
| 2000 Q3 | - AUD | 0.0% |
| 2000 FY | - AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Memphasys Limited | -4.44 Million AUD | 123.757% |
| Race Oncology Limited | -13.81 Million AUD | 107.636% |
| AdAlta Limited | -5.38 Million AUD | 119.61% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | 172.716% |
| Bio-Gene Technology Limited | -2.4 Million AUD | 143.803% |
| CSL Limited | 2.64 Billion AUD | 99.96% |
| Clarity Pharmaceuticals Ltd | -42.32 Million AUD | 102.493% |
| Cynata Therapeutics Limited | -9.74 Million AUD | 110.829% |
| Imugene Limited | -149.68 Million AUD | 100.705% |
| NeuroScientific Biopharmaceuticals Limited | 324.21 Thousand AUD | -225.495% |
| PharmAust Limited | -9.03 Million AUD | 111.683% |
| Proteomics International Laboratories Limited | -6.37 Million AUD | 116.55% |
| Acrux Limited | -5.8 Million AUD | 118.195% |
| Botanix Pharmaceuticals Limited | -13.86 Million AUD | 107.609% |
| Clinuvel Pharmaceuticals Limited | 35.63 Million AUD | 97.039% |
| Island Pharmaceuticals Limited | -2.86 Million AUD | 136.843% |
| Nyrada Inc. | -1.38 Million AUD | 176.127% |
| Orthocell Limited | -7.18 Million AUD | 114.696% |
| Radiopharm Theranostics Limited | -47.94 Million AUD | 102.201% |
| Starpharma Holdings Limited | -8.16 Million AUD | 112.925% |
| Zelira Therapeutics Limited | -36.56 Million AUD | 102.886% |
| Arovella Therapeutics Limited | -8.74 Million AUD | 112.066% |
| Alterity Therapeutics Limited | -19.12 Million AUD | 105.518% |
| Amplia Therapeutics Limited | -4.5 Million AUD | 123.433% |
| Biome Australia Limited | -1.67 Million AUD | 163.183% |
| Biotron Limited | -3.43 Million AUD | 130.708% |
| Chimeric Therapeutics Limited | -12.52 Million AUD | 108.422% |
| EZZ Life Science Holdings Limited | 6.96 Million AUD | 84.848% |
| Immutep Limited | -39.89 Million AUD | 102.645% |
| Invex Therapeutics Ltd | -1.64 Million AUD | 164.276% |
| Noxopharm Limited | -3.57 Million AUD | 129.493% |
| Patrys Limited | -3.53 Million AUD | 129.818% |
| Prescient Therapeutics Limited | -8.23 Million AUD | 112.81% |
| PYC Therapeutics Limited | -37.72 Million AUD | 102.797% |
| Telix Pharmaceuticals Limited | 5.21 Million AUD | 79.749% |
| Dimerix Limited | -17.07 Million AUD | 106.18% |
| Hexima Limited | -933.87 Thousand AUD | 213.001% |
| Neuren Pharmaceuticals Limited | 157.08 Million AUD | 99.328% |
| Nanollose Limited | -1.15 Million AUD | 191.244% |
| Tissue Repair Ltd | -4.13 Million AUD | 125.502% |
| AnteoTech Limited | -8.88 Million AUD | 111.883% |
| Paradigm Biopharmaceuticals Limited | -58.65 Million AUD | 101.799% |
| Recce Pharmaceuticals Ltd | -17.66 Million AUD | 105.975% |
| Avecho Biotechnology Limited | -3.43 Million AUD | 130.708% |
| Actinogen Medical Limited | -13.04 Million AUD | 108.09% |
| Immuron Limited | -6.93 Million AUD | 115.213% |
| Argenica Therapeutics Limited | -5.47 Million AUD | 119.259% |